Hair Relaxer Cancer Lawsuit MDL 3060 — 2026 Update
MDL 3060 has 11,371 plaintiffs — the 3rd-largest MDL in the U.S. NIEHS study (PMID 36245087): frequent users face 2.5x uterine cancer risk. Bellwether trials expected 2027.
Hair Relaxer MDL 3060 Uterine Cancer